Evaluation of the Efficacy and Safety of Lixisenatide Add-On Treatment to Basal Insulin Therapy Among T2DM Patients With Different Body Mass Indices From GetGoal Trials

Diabetology and Metabolic Syndrome - United Kingdom
doi 10.1186/s13098-015-0104-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC